DNDrew M. Nassal

Drew M. Nassal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Drew M. Nassal has a total of 73 co-authors. Here are the top co-authors by number of shared publications:

  • Thomas J. Hund

    Internal Medicine (M.H., T.J.H.), The Ohio State University, Columbus, OH

    9 shared publications
  • Alexander J. Winkle

    The Ohio State University

    3 shared publications
  • Rebecca Shaheen

    The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute (D.M.N., S.M., R.S., H.L., O.C., S.L., A.J.W., J.B.P., N.L., X.X., T.J.H.), College of Medicine, The Ohio State University Wexner Medical Center, Columbus

    3 shared publications
  • Benjamin Buck

    Department of Physiology and Cell Biology (D.M.N., B.B.), College of Medicine, The Ohio State University Wexner Medical Center, Columbus

    2 shared publications
  • David Ryan King

    Graduate Program in Translational Biology, Medicine, and Health (R.L.P., G.A.B., K.E.S., D.R.K.), Virginia Tech, Blacksburg

    2 shared publications
  • Dennison Min

    The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA

    2 shared publications

Latest Publications

  • Open Access

    Role for TREK-1 as a polymodal sensor and regulator of cell activity

    by Alexander J. Winkle, Aparna Odayil Muralidharan, Christian Renee McClenney, Kamellia Karimpour, Taukeed Muhammad Ashfaque, Shaihrum Qureshi, Thomas J. Hund, Drew Nassal

    TREK-1 (KCNK2) is a polymodal two-pore domain potassium (K2P) channel that functions as a background K+ conductance and integrator of mechanical, chemical, and thermal stimuli across diverse cell types. Its unique structure enables sensitivity to membrane stretch, lipid composition, pH, temperature, pharmacologic agents, and intracellular signaling pathways. Beyond shaping resting membrane potential and excitability, TREK-1 engages in noncanonical signaling roles involving protein-protein interactions, trafficking, and modulation of intracellular signaling cascades such as MAPK and calcineurin pathways. TREK-1 is widely expressed in the nervous system, where it regulates neuronal firing, pain sensitivity, mood, and neuroprotection. In the heart, TREK-1 influences action potential duration, mechano-electric feedback, sinoatrial node function, and stress-induced remodeling, with mutations linked to arrhythmogenesis. In fibroblasts and fibroblast-like cells, TREK-1 acts as a mechanotransducer driving differentiation and fibrosis through MAPK signaling. TREK-1 also modulates immune activation, inflammasome signaling, adipogenesis, epithelial injury responses, vascular tone, and cancer cell proliferation. Across tissues, dysregulation of TREK-1 contributes to pathological excitability, fibrosis, inflammation, and degeneration. Given its multimodal regulation and broad impact on cellular function, TREK-1 represents a compelling therapeutic target, though challenges remain due to limited subtype-selective pharmacology and incomplete understanding of its nonionic signaling roles.


  • The β IV -Spectrin/STAT3 Complex Regulates the Orientation of Cardiac Hypertrophic Growth

    by Drew M. Nassal, Shivangi Mohta, Rebecca Shaheen, Haiyan Liu, Omer Cavus, Benjamin Buck, Simon Lococo, Alexander J. Winkle, Jolie B. Pyles, Nicholas Leahy, et al.

    BACKGROUND: Cardiac hypertrophy, defined as a stress-induced increase in heart mass/size, is a major risk factor for adverse cardiovascular events, including heart failure and arrhythmia. Within this general definition, the orientation of cell and organ growth varies considerably depending on stress type and duration, with important implications for cardiac function, yet little is known regarding the mechanisms that regulate hypertrophic orientation. Here, we evaluated the role of the cytoskeletal protein β IV -spectrin and associated prohypertrophic STAT3 (signal transducer and activator of transcription 3) to direct the orientation of hypertrophic growth. METHODS: Transgenic mouse models with altered STAT3 signaling through modified interaction with its scaffolding partner β IV -spectrin, or phospho-regulation of STAT3 directly, were evaluated at baseline, and after transaortic constriction, or aortocaval fistula. Unbiased screening of gene expression from these structurally divergent states was evaluated for pathways responsible for directing myocyte length/width. These pathways were tested in vitro using primary mouse myocytes and in vivo to tune growth patterns for therapeutic intervention. RESULTS: Loss of β IV -spectrin or direct STAT3 activation promoted a preferential increase in myocyte length over width, resulting in dilation of the left ventricular chamber (eccentric hypertrophy) and decreased systolic function. Conversely, preservation of β IV -spectrin favored an increase in myocyte width without left ventricular dilation (concentric hypertrophy) and preserved systolic function in response to transaortic constriction or aortocaval fistula. Differential expression of genes associated with microtubules, including the trafficking kinesin motor, KIF20A (kinesin family member 20A), were identified in concentric versus eccentric hypertrophic states. In vitro assays revealed a relationship between β IV -spectrin/STAT3 signaling, KIF20A expression, microtubule density, and spatial distribution of mRNA for the sarcomeric gene actc1 . Finally, intervention with pharmacological STAT3 inhibition after chronic 6-week transaortic constriction successfully recovered concentric growth with improved systolic function. CONCLUSIONS: These data identify a novel and pivotal role for β IV -spectrin/STAT3 to modify microtubule properties and sarcomeric transcript distribution to direct myocyte geometry in response to chronic stress. These studies further illustrate the unique separation of hypertrophic growth and orientation as distinct pathways in cardiac remodeling.


  • The two-pore K+ channel TREK-1 regulates pressure overload-induced cardiac remodeling

    by Cemantha M. L. Johnson, Drew M. Nassal, Alexander J. Winkle, Benjamin Buck, Xianyao Xu, Xiaoping Wan, Mei Han, Simon Lococo, Nicholas Leahy, Shivangi Mohta, et al.

    A major finding of this study is the involvement of the background K+ channel TREK-1 in modulating STAT3 activation, profibrotic gene expression, and fibrosis with implications for the cardiac remodeling response to chronic pressure overload.


  • Open Access

    Editorial: Functional modifications of ion channels in arrhythmogenesis

    by Drew Nassal, David R. Van Wagoner, Mona El Refaey

    Arrhythmias are a major public health burden and a major cause of morbidity and mortality (Srinivasan and Schilling, 2018). Pharmacologic anti-arrhythmic agents targeting ion channel activity have often triggered pro-arrhythmic outcomes (Saljic et al., 2023). To address this paradox, we sought to provide a comprehensive overview of the functional modifications targeting cardiac ion channels. We were interested in the molecular interventions and/or therapies aimed at inducing/inhibiting these modifications for the treatment of arrhythmia. Our scope was to highlight some of these modifications, evaluate their functional impact, the regulation of upstream pathways and their interaction with physiologic and pathologic signaling pathways. These insights may facilitate the identification of novel physiological targets and the development of novel therapeutics. Our topic includes connexin-43 (Cx-43) and its role in maintaining the electrical rhythm as the only ion channel that has been reported to be subject to internal translation (Kotini et al., 2018). We include the impact of β-adrenergic receptor (β-AR) desensitization in heart failure (HF), and how this downregulation can serve as an adaptive process rather than a detrimental process. Further, the effects of Remdesivir (RDV) on sinoatrial nodal cells were studied, providing foundational mechanistic insights into its future clinical use. Finally, modeling of arrhythmia is a barrier towards new discoveries and traditional animal and cell culture models do not truly reflect human cardiac electro-pathophysiology (van der Velden et al., 2022). Therefore, our topic discusses how patient-specific induced pluripotent stem cells-derived cardiomyocytes (iPSC-CMs) can provide a better personalized platform for arrhythmia monitoring and drug screening.In our topic, Lei et al. reviewed the normal cardiac rhythm propagation and how the breakdown of this process leads to cardiac arrhythmias. They focused on the electrophysiological basis of arrhythmogenesis, highlighting how normal propagation of electrical activation can be disrupted by pro-arrhythmic triggering events. They also described the role of spatial and temporal instability of propagated AP waves in creating an arrhythmic substrate. They reviewed ion channels, the roles of different ion channels in cardiac action potentials, interactions between ion channels, mechanisms of ion channel modifications and ion channel modulation. Finally, they discussed the feedforward and feedback between excitation-contraction coupling and surface membrane processes, including upstream modulatory targets and cardiac remodeling. Further analysis and insight into these physiologic processes enhances understanding of arrhythmic events and identification of novel investigational and immunotherapeutic approaches.Whisenant et al., reviewed the expanding role of Cx-43, focusing on its unique protein modification of internal translation, the only currently identified ion channel to undergo such regulation. The resulting protein, labeled GJA1-20k for its truncated length, was initially identified to promote the trafficking of full-length Cx-43 to the intercalated discs and enhance the canonical role of connexins in supporting cardiac electrical coupling. However, in this review, they emphasized additional roles beyond regulation of electrical coupling by GJA1-20k, which includes promoting cardioprotective effects of ischemic preconditioning in response to ischemia/reperfusion injury. They highlighted studies which attribute the therapeutic action of GJA1-20k and Cx-43 to the regulation of mitochondrial trafficking and fusion/fission balance. Physiologically, they described GJA1-20k expression to be regulated in response to ischemic stress and discussed the detrimental impact of GJA1-20k ablation on both cardiac rhythm and metabolism. They concluded by emphasizing existing and future pursuits to harness GJA1-20k expression for therapeutic opportunities in both cardiac and non-cardiac applications.Mahmood et al. discussed the controversy of β-AR desensitization/downregulation in HF and whether this regulation is a self-preserving or detrimental process. In response to HF, the sympathetic nervous system is activated, and this activation is mediated mainly by the β1-AR. Receptor activation enhances cardiac contractility, relaxation and cardiac output. While short-term sympathetic activation is beneficial, long term sympathetic activation leads to β-AR desensitization and downregulation on the cell membrane. β-AR desensitization has traditionally been considered detrimental in HF progression. Abnormal Ca 2+ handling of cardiac ryanodine receptor (RyR2) and diastolic Ca 2+ leak also occur in HF. The authors discussed how further activation of the β-AR signaling in HF in the presence of RyR2 dysfunction would further aggravate abnormal Ca 2+ handling, cardiac dysfunction, arrhythmogenesis and sudden cardiac death. Therefore, they concluded that β-AR desensitization can be a self-preserving process to protect the failing heart from developing lethal arrhythmic events under sustained sympathetic stimulation in HF.In consideration of therapeutics promoting proarrhythmic behavior, Li et al. described the electrophysiologic effects of remdesivir (RDV), an antiviral drug widely used in COVID-19 treatment. Their study addresses concerns about the potential of RDV to induce clinical symptoms resembling sick sinus syndrome including bradycardia, sinoatrial conduction block, and sinus arrest. To investigate the underlying mechanisms, they employed an in vivo guinea pig model which recapitulated clinical findings of sinus node dysfunction and identified suppression of the pacemaker current, If. Furthermore, the study uncovered the impact of RDV on QT prolongation, which was attributed to inhibition of the hERG channel current (IKr). These findings emphasize the need for more focused monitoring...


  • Open Access

    Cardiac-Specific Deletion of Scn8a Mitigates Dravet Syndrome-Associated Sudden Death in Adults

    by D. Ryan King, Mustafa Demirtas, Mikhail Tarasov, Heather L. Struckman, Xiaolei Meng, Drew Nassal, Nicolae Moise, Alec Miller, Dennison Min, Andrew M. Soltisz, et al.


  • Open Access

    Spectrin-Based Regulation of Cardiac Fibroblast Cell-Cell Communication

    by Drew M. Nassal, Rebecca Shaheen, Nehal J. Patel, Jane Yu, Nick Leahy, Dimitra Bibidakis, Narasimham L. Parinandi, Thomas J. Hund

    Cardiac fibroblasts (CFs) maintain the fibrous extracellular matrix (ECM) that supports proper cardiac function. Cardiac injury induces a transition in the activity of CFs to promote cardiac fibrosis. CFs play a critical role in sensing local injury signals and coordinating the organ level response through paracrine communication to distal cells. However, the mechanisms by which CFs engage cell-cell communication networks in response to stress remain unknown. We tested a role for the action-associated cytoskeletal protein βIV-spectrin in regulating CF paracrine signaling. Conditioned culture media (CCM) was collected from WT and βIV-spectrin deficient (qv4J) CFs. WT CFs treated with qv4J CCM showed increased proliferation and collagen gel compaction compared to control. Consistent with the functional measurements, qv4J CCM contained higher levels of pro-inflammatory and pro-fibrotic cytokines and increased concentration of small extracellular vesicles (30–150 nm diameter, exosomes). Treatment of WT CFs with exosomes isolated from qv4J CCM induced a similar phenotypic change as that observed with complete CCM. Treatment of qv4J CFs with an inhibitor of the βIV-spectrin-associated transcription factor, STAT3, decreased the levels of both cytokines and exosomes in conditioned media. This study expands the role of the βIV-spectrin/STAT3 complex in stress-induced regulation of CF paracrine signaling.


  • Nanoscale remodeling of sodium channels in the cardiac transverse tubules contributes to aberrant calcium release in a Scn1a haploinsufficient mouse

    by David R. King, Mustafa Demirtas, Mikhail Tarasov, Xiaolei Meng, Heather Struckman, Dennison Min, Drew M. Nassal, Thomas J. Hund, Rengasayee Veeraraghavan, Przemyslaw Radwanski

  • Open Access

    Ca2+/calmodulin kinase II–dependent regulation of βIV-spectrin modulates cardiac fibroblast gene expression, proliferation, and contractility

    by Drew M. Nassal, Nehal J. Patel, Sathya D. Unudurthi, Rebecca Shaheen, Jane Yu, Peter J. Mohler, Thomas J. Hund


  • Open Access

    Regulation of Cardiac Conduction and Arrhythmias by Ankyrin/Spectrin-Based Macromolecular Complexes

    by Drew Nassal, Jane Yu, Dennison Min, Cemantha Lane, Rebecca Shaheen, Daniel Gratz, Thomas J. Hund

    The cardiac conduction system is an extended network of excitable tissue tasked with generation and propagation of electrical impulses to signal coordinated contraction of the heart. The fidelity of this system depends on the proper spatio-temporal regulation of ion channels in myocytes throughout the conduction system. Importantly, inherited or acquired defects in a wide class of ion channels has been linked to dysfunction at various stages of the conduction system resulting in life-threatening cardiac arrhythmia. There is growing appreciation of the role that adapter and cytoskeletal proteins play in organizing ion channel macromolecular complexes critical for proper function of the cardiac conduction system. In particular, members of the ankyrin and spectrin families have emerged as important nodes for normal expression and regulation of ion channels in myocytes throughout the conduction system. Human variants impacting ankyrin/spectrin function give rise to a broad constellation of cardiac arrhythmias. Furthermore, chronic neurohumoral and biomechanical stress promotes ankyrin/spectrin loss of function that likely contributes to conduction disturbances in the setting of acquired cardiac disease. Collectively, this review seeks to bring attention to the significance of these cytoskeletal players and emphasize the potential therapeutic role they represent in a myriad of cardiac disease states.